SCHEMBL21140998

SCHEMBL21140998

c1ccc(-c2ccc(-c3ccc(N(c4ccc5c(c4)-c4ccccc4-c4ccccc4-c4ccccc4-5)c4ccc5oc6ccccc6c5c4)cc3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.41
▸ MAPT P10636 4/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ PLA2G2A P14555 5/20 0.39
▸ PLA2G4A P47712 5/20 0.39
▸ LMNA P02545 2/20 0.37
▸ AHR P35869 2/20 0.37
▸ APAF1 O14727 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ XBP1 P17861 1/20 0.37
▸ PTBP1 P26599 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ GALK1 P51570 1/20 0.37
▸ BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21140997 1.00 NPC1 (0.41) NPC1MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL19885392 0.94 NPC1 (0.36) NPC1MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL21141460 0.92 AHR (0.41) NPC1MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL21141461 0.92 AHR (0.41) NPC1MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL24370261 0.92 NPC1 (0.42) NPC1MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL24370381 0.92 NPC1 (0.42) NPC1MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL14295461 0.91 HPGD (0.47) NPC1MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL20906759 0.91 HPGD (0.47) NPC1MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL16639222 0.91 HPGD (0.47) NPC1MAPTRAB9ASMN1; SMN2MEN1
SCHEMBL14295283 0.91 HPGD (0.47) NPC1MAPTRAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11512038-B2 Tetraphenylene triarylamine compounds Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-11-29 — — US disclosed
US-20190185412-A1 TETRAPHENYLENE TRIARYLAMINE COMPOUNDS Beijing Summer Sprout Technology Co., Ltd. (CN) 2019-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11512038-B2 Tetraphenylene triarylamine compounds OCIAD2, OCIAD1, SLC7A5 NPC1 125/4885MAPT 1336/4885RAB9A 1835/4885
US-20190185412-A1 TETRAPHENYLENE TRIARYLAMINE COMPOUNDS OCIAD2, OCIAD1, SLC7A5 NPC1 125/4885MAPT 1336/4885RAB9A 1835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback